-
Mayo Clinic And Oxford Nanopore Team Up, Walgreens Collaboration For Heart Disease Clinical Trial, Qnovia Partners With University Of Virginia
Clinical Research News | Mayo Clinic and Oxford Nanopore Technologies unveils a multi-year joint development collaboration to develop new clinical tests for diseases and improve patient care; Walgreens and the Cardiovascular Research Foundation (CRF) announces a collaboration to drive forward the PREVUE-VALVE study, a population-based clinical trial to quantify the prevalence of valvular heart disease (VHD) among older Americans; Qnovia enters a drug development collaboration with the University of Virginia (UVA) to advance novel inhaled-drug candidates for treating bacterial infections in the lungs; and more.
Oct 26, 2023
-
Follow the Money: Harbinger Health’s Cancer-Screening Platform Study, Clinical Developments, In Vivo Reprogramming Therapies, More
Clinical Research News | Harbinger Health funds 10,000-participant clinical study of its novel blood-based cancer screening platform; Nucleus RadioPharma establishes new radiopharmaceuticals manufacturing facilities; HHS funds behavioral health services and HIV prevention for underserved populations; and more.
Oct 25, 2023
